Skip to content
The People's CodeSearch
Menu

Changes to the Code

H.R. 4139 · Cutting Copays Act ·

In committee · step 2 of 5

Sections are cited like “7 U.S.C. § 2012”: 7 of the , 2012.

42 U.S.C. § 1395w–114 Premium and cost-sharing subsidies for low-income individuals

+8 −01 of 2 shown
More for 42 U.S.C. § 1395w–114
Read § 1395w–114Only this section
2 changes the bill asks for here, 1 carried out
  1. Not carried out:

    by striking that does not exceed $1 for and all that follows through the period at the end and inserting(I) for plan years before plan year 2026— (aa) for a generic drug or a preferred drug that is a multiple source drug (as defined in section 1927(k)(7)(A)(i)), $1 or, if less, the copayment amount applicable to an individual under clause (iii); and (bb) for any other drug, $3 or, if less, the copayment amount applicable to an individual under clause (iii); and that does not exceed—; and

    “that does not exceed $1 for” isn't in § 1395w–114(a)(1)(D)(ii) in the Code as we have it. It was there before, as of Public Law 119-73: the law has changed since the bill was written.

    Technical detail“that does not exceed $1 for” not found in /us/usc/t42/s1395w–114/a/1/D/ii
  2. Carried out:

    by adding at the end the following new subclauses:(II) for plan year 2026— (aa) for a generic drug, $0; and (bb) for any other drug, the dollar amount applied under this clause (after application of paragraph (4)(A)) for plan year 2023 for a drug described in subclause (I)(bb); and (III) for a subsequent year, the dollar amount …

    The section already has a provision under this letter or number, so it would have two.

This bill puts a provision under a letter or number this section already uses, so the section would have two. The law has probably changed since the bill was written.

1 of the 2 changes this bill asks for here names words or provisions the section had before but doesn't now: the law has changed since the bill was written, so it is not marked.

§ 1395w–114(a)(1)(D)Reduction in cost-sharing below out-of-pocket threshold(ii)–(iii)

Start of § 1395w–114 to (a)(1)(D)(ii)(II)(aa) unchanged ·

(bb) for a preferred drug that is a multiple source drug (as defined in section 1396r–8(k)(7)(A)(i) of this title), the dollar amount applied under this clause for such a drug for the preceding plan year, increased by the annual percentage increase in the consumer price index (all items; U.S. city average) as of September of such preceding year, or, if less, the copayment amount applicable to an individual under clause (iii); and

(cc) for a drug not described in either item (aa) or (bb), the dollar amount applied under this clause for such a drug for the preceding plan year, increased in the manner specified in item (bb), or, if less, the copayment amount applicable to an individual under clause (iii).

(II) [inserted: for plan year 2026—]

(aa) [inserted: for a generic drug, $0; and]

(bb) [inserted: for any other drug, the dollar amount applied under this clause (after application of paragraph (4)(A)) for plan year 2023 for a drug described in subclause (I)(bb); and]

(III) [inserted: for a subsequent year, the dollar amount applied under this clause for the previous year for the drug, increased by the annual percentage increase in the consumer price index (all items; U.S. city average) as of September of such previous year.]

Any amount established under item (bb) or (cc) of subclause (II), that is based on an increase of $1 or $3, that is not a multiple of 5 cents or 10 cents, respectively, shall be rounded to the nearest multiple of 5 cents or 10 cents, respectively.

(iii) Other individuals Subject to paragraph (6), in the case of an individual not described in clause (i) or (ii), the substitution for the beneficiary coinsurance described in section 1395w–102(b)(2) of this title (for all amounts through the total amount of expenditures at which benefits are available under section 1395w–102(b)(4) of this title) of a copayment amount that does not exceed the copayment amount specified under section 1395w–102(b)(4)(A)(i)(I)(aa) of this title for the drug and year involved. For plan year 2023 and subsequent plan years, the copayment amount applicable under the preceding sentence to a month’s supply of a covered insulin product (as defined in section 1395w–102(b)(9)(C) of this title) dispensed to the individual may not exceed the applicable copayment amount for the product under the prescription drug plan or MA–PD plan in which the individual is enrolled.

Rest of § 1395w–114 unchanged ·

Step through the changes